Stockscreener 앱 받기
2.05
5.67%
0.11
시간 외 거래:
2.06
0.01
+0.49%
Ventyx Biosciences Inc 주식(VTYX)의 최신 뉴스
Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) high institutional ownership speaks for itself as stock continues to impress, up 10% over last week - Simply Wall St
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Acquired by Barclays PLC - Defense World
JPMorgan Chase & Co. Has $2.20 Million Holdings in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World
What is HC Wainwright’s Estimate for VTYX FY2024 Earnings? - Defense World
HC Wainwright Analysts Increase Earnings Estimates for VTYX - MarketBeat
FY2029 Earnings Estimate for VTYX Issued By HC Wainwright - Defense World
Research Analysts Set Expectations for VTYX FY2029 Earnings - MarketBeat
Ventyx Biosciences Discloses Preliminary 2024 Financials and Pipeline Strategy - Defense World
Ventyx Biosciences highlights its 2025 pipeline strategy - Yahoo Finance
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Sold by Jane Street Group LLC - Defense World
Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio - GlobeNewswire
Ventyx Biosciences advances NLRP3 inhibitor trials By Investing.com - Investing.com Canada
HC Wainwright Reaffirms Neutral Rating for Ventyx Biosciences (NASDAQ:VTYX) - MarketBeat
Ventyx Biosciences highlights 2025 pipeline strategy and provides clinical updates; shares rise - MSN
Ventyx Biosciences Unveils 2025 Pipeline and Clinical Updates - TipRanks
Ventyx Biosciences advances NLRP3 inhibitor trials - Investing.com
Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on Its Nlrp3 Inhibitor Portfolio - Marketscreener.com
Ventyx Biosciences Inc’s (VTYX) -10.71% Retreat Justifies A Second Look - Stocks Register
We're Keeping An Eye On Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate - Yahoo Finance
Barclays PLC Increases Position in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World
Geode Capital Management LLC Has $3.03 Million Stock Position in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World
State Street Corp Acquires 9,783 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World
Ventyx Biosciences chief scientific officer sells $49,840 in stock By Investing.com - Investing.com Australia
Ventyx Biosciences chief scientific officer sells $49,840 in stock - Investing.com India
John Nuss Sells 21,119 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) Stock - MarketBeat
Ventyx Biosciences director Sheila Gujrathi buys $300,573 in stock - Investing.com India
Sheila Gujrathi Buys 130,000 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) Stock - MarketBeat
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Insider John Nuss Sells 13,161 Shares - MarketBeat
Ventyx Biosciences' chief scientific officer sells $29,682 in stock - Investing.com
Ventyx Biosciences' chief scientific officer sells $29,682 in stock By Investing.com - Investing.com UK
Insiders Enjoy US$190k Return After Buying Ventyx Biosciences Stock - Simply Wall St
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Ventyx Biosciences Insiders Land Bargain With Gains Of US$180k - Yahoo Finance
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Cryopyrin-associated Periodic Syndromes Market on Track for Major Expansion by 2034, According to DelveInsight | Amgen, Biovitrum, Novartis, Ventyx Biosciences - The Globe and Mail
Neurogene and Ventyx Biosciences rises after insider buying by executives - MSN
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Bought by Vestal Point Capital LP - MarketBeat
Sio Capital Management LLC Raises Stock Holdings in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - MarketBeat
Hedge Fund and Insider Trading News: Bill Ackman, Paul Tudor Jones, Whitney Tilson, Steven Cohen, Scott Bessent, Millennium Management, Paloma Partners, Ventyx Biosciences Inc (VTYX), Vistra Corp (VST), and More - Insider Monkey
Ventyx Biosciences Inc (NASDAQ: VTYX) Jumps 11.35%, Turning Investors Away - Stocks Register
Ventyx Biosciences CEO Mohan Raju buys $959,889 in stock By Investing.com - Investing.com Nigeria
Ventyx Biosciences CEO Mohan Raju buys $959,889 in stock - Investing.com
Analysts Set Ventyx Biosciences, Inc. (NASDAQ:VTYX) Price Target at $10.00 - MarketBeat
5.49%
0.79%
자본화:
|
볼륨(24시간):